Amy E. Monaghan
Impact in
-
- Neuropeptides and Animal Physiology
-
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Ubiquitin and proteasome pathways 1
-
- Cholinesterase and Neurodegenerative Diseases 5
- Co-authors
- Wen Chiy Liew (1 shared paper)Michael Spedding (1 shared paper)Tom I. Bonner (1 shared paper)S P H Alexander (1 shared paper)Chidochangu P. Mpamhanga (1 shared paper)Joanna L Sharman (1 shared paper)Richard R. Neubig (1 shared paper)Jean‐Philippe Pin (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)Assay and Drug Development Technologies (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)MedChemComm (1 paper)Pharmacological Reviews (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Amy E. Monaghan
12 papers receiving 378 citations
Peers
Comparison fields: 5 of 64
- Cellular and Molecular Neuroscience 84
- Biochemistry 31
- Pharmacology 63
- Physiology 17
- Molecular Biology 228
Countries citing papers authored by Amy E. Monaghan
This map shows the geographic impact of Amy E. Monaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Monaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Monaghan more than expected).
Fields of papers citing papers by Amy E. Monaghan
This network shows the impact of papers produced by Amy E. Monaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Monaghan. The network helps show where Amy E. Monaghan may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Monaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 260 | |
| 2 | 2019 | 23 | |
| 3 | 2021 | 21 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 15 | |
| 6 | 2019 | 14 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 8 | |
| 9 | 2022 | 5 | |
| 10 | 2019 | 4 | |
| 11 | 2017 | 2 | |
| 12 | 2025 | 1 | |
| 13 | Course Development in Distance Education: Whose is the Content? | 2008 | 1 |
About Amy E. Monaghan
Amy E. Monaghan is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 13 papers that have together received 381 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (5 papers), Computational Drug Discovery Methods (3 papers), Prostate Cancer Treatment and Research (2 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (84 citations), Biochemistry (31 citations), Pharmacology (63 citations), Physiology (17 citations) and Molecular Biology (228 citations). Amy E. Monaghan has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Wen Chiy Liew, Michael Spedding, Tom I. Bonner, S P H Alexander, Chidochangu P. Mpamhanga, Joanna L Sharman, Richard R. Neubig, Jean‐Philippe Pin, Adam J Pawson and Anthony P. Davenport. Their work appears in journals such as Journal of Medicinal Chemistry, Assay and Drug Development Technologies, Bioorganic & Medicinal Chemistry Letters, MedChemComm and Pharmacological Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.